The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus

被引:9
|
作者
Sanabria-de la Torre, Raquel [1 ,2 ]
Garcia-Fontana, Cristina [2 ,3 ,4 ]
Gonzalez-Salvatierra, Sheila [1 ,2 ]
Andujar-Vera, Francisco [2 ,5 ,6 ]
Martinez-Heredia, Luis [1 ,2 ]
Garcia-Fontana, Beatriz [2 ,3 ,4 ]
Munoz-Torres, Manuel [1 ,2 ,3 ,4 ]
机构
[1] Univ Granada, Dept Med, Granada 18016, Spain
[2] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada 18012, Spain
[3] Univ Hosp Clin San Cecilio, Endocrinol & Nutr Unit, Granada 18016, Spain
[4] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid 28029, Spain
[5] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada 18071, Spain
[6] Andalusian Res Inst Data Sci & Computat Intellige, Granada 18014, Spain
关键词
cardiovascular disease; microvascular disease; macrovascular disease; type 2 diabetes mellitus; Wnt pathway; PERIPHERAL ARTERIAL-DISEASE; BETA-CATENIN; RENAL-INSUFFICIENCY; SERUM SCLEROSTIN; ENDOTHELIAL-CELL; EXPRESSION; PATHWAY; HYPERTENSION; BRAIN; GROWTH;
D O I
10.3390/ijms23136995
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular complications are the leading cause of morbidity and mortality among patients with type 2 diabetes mellitus (T2DM). These vascular abnormalities result in a chronic hyperglycemic state, which influences many signaling molecular pathways that initially lead to increased oxidative stress, increased inflammation, and endothelial dysfunction, leading to both microvascular and macrovascular complications. Endothelial dysfunction represents the initial stage in both types of vascular complications; it represents "mandatory damage" in the development of microvascular complications and only "introductory damage" in the development of macrovascular complications. Increasing scientific evidence has revealed an important role of the Wnt pathway in the pathophysiology of the vascular wall. It is well known that the Wnt pathway is altered in patients with T2DM. This review aims to be an update of the current literature related to the Wnt pathway molecules that are altered in patients with T2DM, which may also be the cause of damage to the vasculature. Both microvascular complications (retinopathy, nephropathy, and neuropathy) and macrovascular complications (coronary artery disease, cerebrovascular disease, and peripheral arterial disease) are analyzed. This review aims to concisely concentrate all the evidence to facilitate the view on the vascular involvement of the Wnt pathway and its components by highlighting the importance of exploring possible therapeutic strategy for patients with T2DM who develop vascular pathologies.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Association of Mean Platelet Volume With Vascular Complications in the Patients With Type 2 Diabetes Mellitus
    Brahmbhatt, Krutik J.
    Chaudhary, Bharat
    Raval, Darshankumar M.
    Mallik, Shashwat
    Khan, Shahin
    Patel, Mayur
    Patel, Nirav
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [32] The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus
    Liang, Wei
    Ye, Dong Dong
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 48 : 32 - 39
  • [33] Guidelines for medical management of type 2 diabetes - Treatment of associated vascular risk factors and complications of type 2 diabetes mellitus
    不详
    PRESSE MEDICALE, 1999, 28 (29): : 1584 - 1589
  • [34] The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
    Jin, Tianru
    Liu, Ling
    MOLECULAR ENDOCRINOLOGY, 2008, 22 (11) : 2383 - 2392
  • [35] Is type 2 diabetes mellitus a vascular condition?
    Hu, FB
    Stampfer, MJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (10) : 1715 - 1716
  • [36] The Genetics of Vascular Complications in Diabetes Mellitus
    Farbstein, Dan
    Levy, Andrew P.
    CARDIOLOGY CLINICS, 2010, 28 (03) : 477 - +
  • [37] TREATMENT OF VASCULAR COMPLICATIONS OF DIABETES MELLITUS
    KROSNICK, A
    MODERN TREATMENT, 1967, 4 (01): : 85 - &
  • [38] VASCULAR COMPLICATIONS IN DIABETES-MELLITUS
    WILLIAMSON, JR
    KILO, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (07): : 399 - 400
  • [39] Biomarkers of vascular complications in type 2 diabetes
    Tremblay, Johanne
    Hamet, Pavel
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (03): : S28 - S32
  • [40] Screening for vascular complications in children and adolescents with type 1 diabetes mellitus
    Chiarelli, F
    Mohn, A
    Tumini, S
    Trotta, D
    Verrotti, A
    HORMONE RESEARCH, 2002, 57 : 113 - 116